These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 28094532
1. Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties. Siwowska K, Haller S, Bortoli F, Benešová M, Groehn V, Bernhardt P, Schibli R, Müller C. Mol Pharm; 2017 Feb 06; 14(2):523-532. PubMed ID: 28094532 [Abstract] [Full Text] [Related]
2. Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates. Müller C, Guzik P, Siwowska K, Cohrs S, Schmid RM, Schibli R. Molecules; 2018 Jun 16; 23(6):. PubMed ID: 29914162 [Abstract] [Full Text] [Related]
3. Design and Evaluation of Novel Albumin-Binding Folate Radioconjugates: Systematic Approach of Varying the Linker Entities. Benešová M, Guzik P, Deberle LM, Busslinger SD, Landolt T, Schibli R, Müller C. Mol Pharm; 2022 Mar 07; 19(3):963-973. PubMed ID: 35192367 [Abstract] [Full Text] [Related]
4. DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice. Müller C, Struthers H, Winiger C, Zhernosekov K, Schibli R. J Nucl Med; 2013 Jan 07; 54(1):124-31. PubMed ID: 23236020 [Abstract] [Full Text] [Related]
5. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate. Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C. Mol Pharm; 2016 Jun 06; 13(6):1979-87. PubMed ID: 27145400 [Abstract] [Full Text] [Related]
6. Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy. Haller S, Reber J, Brandt S, Bernhardt P, Groehn V, Schibli R, Müller C. Nucl Med Biol; 2015 Oct 06; 42(10):770-9. PubMed ID: 26162583 [Abstract] [Full Text] [Related]
7. Preclinical development of small-molecular-weight folate-based radioconjugates: a pharmacological perspective. Siwowska K, Müller C. Q J Nucl Med Mol Imaging; 2015 Sep 06; 59(3):269-86. PubMed ID: 26149341 [Abstract] [Full Text] [Related]
8. Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast. Reber J, Struthers H, Betzel T, Hohn A, Schibli R, Müller C. Mol Pharm; 2012 May 07; 9(5):1213-21. PubMed ID: 22509996 [Abstract] [Full Text] [Related]
9. Reduced 18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging. Boss SD, Müller C, Siwowska K, Büchel JI, Schmid RM, Groehn V, Schibli R, Ametamey SM. Bioconjug Chem; 2018 Apr 18; 29(4):1119-1130. PubMed ID: 29412638 [Abstract] [Full Text] [Related]
10. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors. Müller C, Schubiger PA, Schibli R. Nucl Med Biol; 2007 Aug 18; 34(6):595-601. PubMed ID: 17707798 [Abstract] [Full Text] [Related]
11. Albumin-Binding PSMA Ligands: Optimization of the Tissue Distribution Profile. Benešová M, Umbricht CA, Schibli R, Müller C. Mol Pharm; 2018 Mar 05; 15(3):934-946. PubMed ID: 29400475 [Abstract] [Full Text] [Related]
12. Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates. Busslinger SD, Becker AE, Vaccarin C, Deberle LM, Renz ML, Groehn V, Schibli R, Müller C. Cancers (Basel); 2023 Aug 25; 15(17):. PubMed ID: 37686538 [Abstract] [Full Text] [Related]
13. Novel Synthetic Strategies Enable the Efficient Development of Folate Conjugates for Cancer Radiotheranostics. Deberle LM, Benešová M, Becker AE, Ratz M, Guzik P, Schibli R, Müller C. Bioconjug Chem; 2021 Aug 18; 32(8):1617-1628. PubMed ID: 34251183 [Abstract] [Full Text] [Related]
14. Improved PET imaging of tumors in mice using a novel (18) F-folate conjugate with an albumin-binding entity. Fischer CR, Groehn V, Reber J, Schibli R, Ametamey SM, Müller C. Mol Imaging Biol; 2013 Dec 18; 15(6):649-54. PubMed ID: 23760583 [Abstract] [Full Text] [Related]
15. Preclinical Development of Novel PSMA-Targeting Radioligands: Modulation of Albumin-Binding Properties To Improve Prostate Cancer Therapy. Umbricht CA, Benešová M, Schibli R, Müller C. Mol Pharm; 2018 Jun 04; 15(6):2297-2306. PubMed ID: 29684274 [Abstract] [Full Text] [Related]
16. Comparative Studies of Three Pairs of α- and γ-Conjugated Folic Acid Derivatives Labeled with Fluorine-18. Boss SD, Betzel T, Müller C, Fischer CR, Haller S, Reber J, Groehn V, Schibli R, Ametamey SM. Bioconjug Chem; 2016 Jan 20; 27(1):74-86. PubMed ID: 26634288 [Abstract] [Full Text] [Related]
17. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. Müller C, Mindt TL, de Jong M, Schibli R. Eur J Nucl Med Mol Imaging; 2009 Jun 20; 36(6):938-46. PubMed ID: 19183997 [Abstract] [Full Text] [Related]
18. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo. Müller C, Brühlmeier M, Schubiger PA, Schibli R. J Nucl Med; 2006 Dec 20; 47(12):2057-64. PubMed ID: 17138750 [Abstract] [Full Text] [Related]
19. Tumor targeting using 67Ga-DOTA-Bz-folate--investigations of methods to improve the tissue distribution of radiofolates. Müller C, Vlahov IR, Santhapuram HK, Leamon CP, Schibli R. Nucl Med Biol; 2011 Jul 20; 38(5):715-23. PubMed ID: 21718947 [Abstract] [Full Text] [Related]
20. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM. Bioconjug Chem; 2008 Dec 20; 19(12):2462-70. PubMed ID: 19053298 [Abstract] [Full Text] [Related] Page: [Next] [New Search]